These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3268925)

  • 1. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants.
    Krogh V; Duffy LC; Wong D; Rosenband M; Riddlesberger KR; Ogra PL
    J Lab Clin Med; 1989 Jun; 113(6):695-9. PubMed ID: 2732617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 7. Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey.
    Valensin PE; Cusi MG; Zanchi A; Rossolini GM; Cellesi C; Amato T
    Microbiologica; 1988 Apr; 11(2):119-27. PubMed ID: 3405097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and the rubella-specific immune response following vaccination.
    Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
    Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella immunization of teenage girls in Iceland and follow-up after a severe rubella epidemic.
    Rafnar B
    Bull World Health Organ; 1982; 60(1):141-6. PubMed ID: 6979417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
    Müller G; Baumann H
    Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS
    Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiologic situation of rubella in Italy 20 years after the introduction of the vaccine].
    Galli MG
    Ann Ig; 1989; 1(1-2):247-54. PubMed ID: 2483071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the immune status in a female population sample 10 years after rubella vaccination].
    Becchi A; Fornero M; Mantovani G
    Nuovi Ann Ig Microbiol; 1985; 36(4):305-11. PubMed ID: 3842769
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.